Medicinal chemistry of aldose reductase inhibitors
1988; Wiley; Volume: 8; Issue: 2 Linguagem: Inglês
10.1002/med.2610080202
ISSN1098-1128
AutoresEric R. Larson, Christopher A. Lipinski, Reinhard Sarges,
Tópico(s)Plant Toxicity and Pharmacological Properties
ResumoMedicinal Research ReviewsVolume 8, Issue 2 p. 159-186 Article Medicinal chemistry of aldose reductase inhibitors Eric R. Larson, Eric R. Larson Pfizer, Central Research, Groton, Connecticut 06340Search for more papers by this authorChristopher A. Lipinski, Christopher A. Lipinski Pfizer, Central Research, Groton, Connecticut 06340Search for more papers by this authorReinhard Sarges, Reinhard Sarges Pfizer, Central Research, Groton, Connecticut 06340Search for more papers by this author Eric R. Larson, Eric R. Larson Pfizer, Central Research, Groton, Connecticut 06340Search for more papers by this authorChristopher A. Lipinski, Christopher A. Lipinski Pfizer, Central Research, Groton, Connecticut 06340Search for more papers by this authorReinhard Sarges, Reinhard Sarges Pfizer, Central Research, Groton, Connecticut 06340Search for more papers by this author First published: April/June 1988 https://doi.org/10.1002/med.2610080202Citations: 32AboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL Share a linkShare onEmailFacebookTwitterLinkedInRedditWechat References 1 P. F. Kador, W. G. Robison, Jr., and J. H. Kinoshita, Ann. Rev. Pharmacol. Toxicol., 25, 691 (1985). 2 P. F. Kador, Ophthalmol., 90, 352 (1983). 3 P. F. Kador, J. H. Kinoshita, and N. E. Sharpless, J. Med. Chem., 28, 841 (1985). 4 C. A. Lipinski and N. J. Hutson, Ann. Rep. Med. Chem., 19, 169 (1984). 5 Metabolism Clinical and Experimental, 35, No. 4 Suppl., 1, April 1986. 6 S. Hayman and J. H. Kinoshita, J. Biol. Chem., 240, 877 (1965). 7 J. H. Kinoshita, D. Dvornik, M. Kraml, and K. H. Gabbay, Biochim. Biophys. Acta, 158, 472 (1968). 8 J. C. Hutton, P. J. Schofield, J. F. Williams, and F. C. Hollows, Biochem. Pharmacol., 23, 2991 (1974). 9 R. Sarges and M. J. Peterson, Metabolism, 35, No. 4 Suppl. 1, , 101 (1986). 10 M. J. Peterson, R. Sarges, C. E. Aldinger, and D. P. MacDonald, Metabolism, 28, Suppl. 1, 456 (1979). 11 B. L. Mylari, M. W. Miller, H. L. Howes, S. K. Figdor, J. E. Lynch, and R. C. Koch, J. Med. Chem., 20, 475 (1977). 12 D. Dvornik, N. Simard-Duquesne, M. Kraml, K. Sestanj, K. H. Gabbay, J. H. Kinoshita, S. D. Varma, and L. O. Merola, Science, 182, 1146 (1973). 13 R. Sarges, J. Bordner, B. W. Dominy, M. J. Peterson, and E. B. Whipple, J. Med. Chem., 28, 1716 (1985). 14 P. F. Kador and N. E. Sharpless, Mol. Pharmacol., 24, 521 (1983). 15 R. A. Ronfeld, Pfizer Central Research, Groton, CT, unpublished observations. 16 Y. Kawakami, Y. Nagai, H. Ono, K. Ueda, T. Sato, and S. Tanaka, Heterocycles, 21, 583 (1984). 17 N. Nakai, Y. Fujii, K. Kobashi, and K. Nomura, Arch. Biochem. Biophys., 239, 491 (1985). 18 H. Ono, Y. Nozawa, and S. Hayano, Nippon Ganka Gakkai Zasshi, 86, (9), 253 (1982). 19 R. C. Schnur, R. Sarges, and M. J. Peterson, J. Med. Chem., 25, 1451 (1982). 20 A. B. Richon, M. E. Maragoudakis, and J. S. Wasvary, J. Med. Chem., 25, 745 (1982). 21 D. R. Brittain, Spec. Publ.-R. Soc. Chem. 1986, 55 (SCI-RSC Med. Chem. Symp., 3rd., 1985), 210–240. 22 B. W. Griffin, M. L. Chandler, and L. DeSantis, ARVO Abstracts. Invest. Ophthalmol. Vis. Sci. 26(Suppl.), 136 (1986). 23 B. M. York, Jr., European Patent 0 092 385, April 14, 1983. 24 B. M. York, Jr., United States Patent 4,438,272, March 20, 1984. 25 P. Müller, O. Hockwin, and C. Ohrloff, Ophthalmic Res., 17, 115 (1985). 26 B. M. York, Jr., European Patent 0 137 333, Dec. 9, 1984. 27 T. Sohda, K. Mizuno, E. Imamiya, H. Tawada, K. Meguro, Y. Kawamatsu and Y. Yamamoto, Chem. Pharm. Bull., 30, 3601 (1982). 28 K. Inagaki, I. Miwa, Y. Yashiro, and J. Okuda, Chem. Pharm. Bull., 30, 3244 (1982). 29 R. Kikkawa, I. Hatanaka, and Y. Shigeta, Frontiers in Diabetes, Diabetic Microangiopathy, H. Abe and M. Hoshi, Eds., Karger, Basel, New York, 1983, Vol. 3, p. 195. 30 K. Mizuno, T. Sohda, K. Meguro, and Y. Kawamatsu, J. Takeda Res. Lab., 42, 227 (1983). 31 T. Doi, T. Tsukamoto, H. Torii, K. Yoshida, and S. Tanayama, J. Takeda Res. Lab., 43, 19 (1984). 32 I. Miwa, K. Inagaki, T. Yashiro, and J. Okuda, Chem. Pharm. Bull., 32, 2030 (1984). 33 J. Okuda, K. Yashima, K. Inagaki, and I. Miwa, Chem. Pharm. Bull., 33, 2990 (1985). 34 K. Sestanj, F. Bellini, S. Fung, N. Abraham, A. Treasurywala, L. Humber, N. Simard-Duqeusne, and D. Dvornik, J. Med. Chem., 27, 255 (1984). 35 H-K. Lee and G. Querijero, J. Pharm. Sci., 74, 273 (1985). 36 N. Simard-Duquesne, E. Greselin, J. Dubuc, and D. Dvornik, Metab. Clin. Exp., 31, 885 (1985). 37 N. Simard-Duquesne, E. Greselin, R. Gonzalez, and D. Dvornik, Proc. Soc. Exp. Biol. Med., 178, 599 (1985). 38 W. G. Robison, P. F. Kador, Y. Akagi, J. H. Kinoshita, R. Gonzalez, and D. Dvornik, Diabetes, 35, 295 (1986). 39 D. R. Hicks, M. Kraml, M. N. Cayen, J. Dubuc, S. Ryder, and D. Dvornik, Clin. Pharmacol. Ther., 36, 493 (1984). 40 M. N. Cayen, D. R. Hicks, E. S. Ferdinandi, M. Kraml, E. Greselin, and D. Dvornik, Drug Metab. Disp., 13, 412 (1985). 41 D. R. Hicks, M. Kraml, M. N. Cayen, J. Dubuc, S. Ryder, and D. Dvornik, Clin. Pharmacol. Ther., 36, 493 (1984). 42 D. Dvornik, R. Gonzalez, D. Hicks, T. Smith, S. Ryder, J. F. Mullane, P. Raskin, J. Rosenstock, P. Challis, J. Caro, and W. Fore, Diabetes Research and Clinical Practice, Suppl. 1, 5146 (1985). 43 L. Koglin, C. Clark, S. Ryder, and J. F. Mullane, Diabetes, 34, Suppl. 1, 202A (1985). 44 J. Fagius and S. Jameson, J. Neurol. Neurosurg. Psychiatry, 44, 941 (1981). 45 D. J. Handelsman and J. R. Turtle, Diabetes, 30, 459 (1981). 46 A. Culebras, J. Alio, J. L. Herrara, and M. I. Lopez-Fraile, Arch. Neurol., 38, 133 (1981). 47 P. F. Kador, J. D. Goosey, N. E. Sharpless, J. Kolish, and D. Miller, Eur. J. Med. Chem., 16, 293 (1981). 48 D. Stribling, and D. R. Brittain, Innovative Approaches in Drug Research, A. F. Harms, Ed., Elsevier, Amsterdam, 1986, p. 297. 49 D. R. Tomlinson, J. Townsend, and P. Fretten, Diabetes, 34, 970 (1985). 50 D. Stribling, D. J. Mirrlees, H. E. Harrison, and D. C. N. Earl, Metabolism, 34, 336 (1985). 51 D. Stribling, D. J. Mirrlees, and D. C. N. Earl, Diabetologia, 25, 196 (1983). 52 S. C. Norris, C. M. Perkins, W. Bastian, D. Mirrlees, and R. A. Yates, Clin. Sci., 69, Suppl. 12, 22P, 1985. 53 R. Poulsom and H. Heath, Biochem. Pharmacol., 32, 1495 (1983). 54 R. Boot-Hanford and H. Heath, Biochem. Pharmacol., 30, 3065 (1981). 55 R. Poulsom, R. P. Boot-Hanford, and H. Heath, Exp. Eye. Res., 37, 507 (1983). 56 H. Terashima, K. Hama, R. Yamamoto, M. Tsuboshima, R. Kikkawa, I. Hatanaka, and Y. Shigeta, J. Pharm. Exp. Therapeut., 229, 226 (1984). 57 R. Kikkawa, I. Hatanaka, H. Yasuda, N. Kobayashi, Y. Shigeta, H. Terashima, T. Morimura, and M. Tsuboshima, Diabetologia, 24, 290 (1983). 58 R. Kikkawa, I. Hatanaka, H. Yasuda, N. Kobayashi, and Y. Shigeta, Metabolism, 33, 212 (1984). 59 N. Hotta, H. Kakuta, H. Fukasawa, M. Kimura, N. Koh, M. Iida, H. Terashima, T. Morimura, and N. Sakamoto, Diabetologia, 28, 176 (1985). 60 K. Kojima, H. Matsubara, T. Harada, K. Mizuno, J. Suzuki, N. Hotta, H. Kakuita, and N. Sakamoto, Jpn. J. Ophthalmol., 29, 99 (1985). 61 N. Kaman, H. Mabuchi, and R. Takeda, Diabetes Res. Clin. Pract., 1(Suppl.), 251 (1985). 62 G. Okuno, A. Oki, T. Yamazaki, S. Shibamoto, H. Fukuda, T. Kashiwara, K. Sakuyama, F. Kawakami, and H. Tako, Diabetes Res. Clin. Pract., 1(Suppl.), 420 (1985). 63 E. Kato, K. Yamamoto, T. Baba, T. Watanabe, Y. Kawashima, H. Masuda, M. Horiuchi, M. Oya, T. Iso, and J.-I. Iwao, Chem. Pharm. Bull., 33, 74 (1985). 64 E. Kato, K. Yamamoto, T. Baba, T. Watanabe, Y. Kawashima, M. Horiuch, M. Oya, T. Iso, and J.-I. Iwao, Chem. Pharm. Bull., 33, 5341 (1985). 65 A. N. Brubaker, J. DeRuiter, and W. L. Whitmer, J. Med. Chem., 29, 1094 (1986). 66 W. W. Van Den Hoven, D. W. R. Hall, and J. W. Burns, Br. J. Clin. Practice, (Symp. Suppl.), 34, 31 (1984). 67 Y. R. Sharma and E. Cotlier, Exp. Eye. Res., 35, 21 (1982). 68 M. Jacobson, Y. R. Sharma, E. Cotlier, and J. D. Hollander, Invest. Ophthalmol. Vis. Sci., 24, 1426 (1983). 69 W. F. Williams and J. D. Odom, Science, 233, 223 (1986). 70 M. J. C. Crabbe, G. Freeman, A. B. Haider, and A. J. Bron, Ophthalmic Res., 17, 85 (1985). 71 J. G. Cunha Vaz, C. C. Mota, E. C. Leite, J. R. Abreu, and M. A. Ruas, Arch. Ophthalmol., 103, 1307 (1985). 72 J. G. Cunha Vaz, C. Mota, E. Leite, J. R. Faria Abreu, and M. A. Ruas, Diabetes, 34, Suppl. 1, 109A (1985). 73 E. Cotlier and Y. R. Sharma, Lancet, 1, 358 (1981). 74 E. Cotlier, Y. R. Sharma, T. Niven, and M. Brescia, Am. J. Med., 74(6A), 83 (1983). 75 E. Cotlier and Y. R. Sharma, Lancet, 1, 607 (1980). 76 J. F. Day, R. W. Thornberg, S. R. Thorpe, and J. W. Baynes, J. Biol. Chem., 254, 9394 (1979). 77 G. N. Rao and E. Cotlier, Invest. Ophthalmol. Vis. Set., 27, 98 (1986). 78 V. M. Monnier, V. Vishwanath, K. E. Frank, C. A. Elmets, P. Dauchot, and R. R. Kohn, N. Engl. J. Med., 314, 403 (1986); Editorial, Lancet, 1, 1192 (1986). 79 M. Testa, G. Luliano, and B. Silvestrini, Lancet, 1, 849 (1982). 80 L. Bonomi, G. Marchini, I. DeFranco, S. Perfetti, and M. DeGregorio, Curr. Ther. Res., 33, 727 (1983). 81 B. Silvestrini, B. Catanese, G. Barrillari, E. Lorio, and I'. Valeri, Int. J. Tiss. Reac., V, 217 (1983). 82 L. Pandolfo, M. A. Livrea, and A. Bono, Exp. Eyc. Res., 42, 167 (1986). 83 J. R. Pfister, W. E. Wymann, J. M. Mahoney, and L. D. Waterbury, J. Med. Chem., 23, 1264 (1980). 84 A. Beyer-Mears, E. Cruz, J. Nicolas-Alexandra, and E. Varagiannis, Arch. Int. Pharmacodyn. Ther., 259, 166 (1982). 85 G. J. White, Agents Actions, 11, 503 (1981). 86 P. F. Kador, N. E. Sharpless, and J. D. Goosey, Prog. Clin. Biol. Res., 114, 243 (1982). 87 B. V. Cheney, J. B. Wright, C. M. Hall, and R. E. Christofferson, J. Med. Chem., 21, 980 (1978). 88 P. F. Kador and N. E. Sharpless, Biophys. Chem., 8, 81 (1978). 89 S. R. Whittle and A. J. Turner, Biochem. Pharmacol., 11, 1191 (1981). 90 M. Shimizu, T. Ito, S. Terashima, T. Hayashi, M. Arisawa, N. Morita, S. Kurokawa, K. Ito, and Y. Hashimoto, Phytochemistry, 23, 1885 (1984). 91 P. S. Chaudhry, J. Cabrera, H. R. Juliani, and S. D. Varma, Biochem. Pharmacol., 32, 1995 (1983). 92 S. D. Varma, A. Mizuno, and J. H. Kinoshita, Science, 195, 205 (1977). 93 J. Okuda, I. Miwa, K. Inagaki, T. Horie, and M. Nakayama, Chem. Pharm. Bull., 32, 764 (1984). 94 J. Okuda, I. Miwa, K. Inagaki, T. Horie, and M. Nakayama, Biochem. Pharmacol., 31, 3807 (1982). 95 S. D. Varma and J. H. Kinoshita, Biochem. Pharmacol., 25, 2505 (1976). 96 H. Ono and S. Hayano, Nippon Ganka, Gakkai Zasshi, 86, (4), 353 (1982). 97 J. Santos, L. B. A. Mira, A. M. Freire, M. Azevedo, and C. Manso, Acta. Med. Portuguesa, 5, 115 (1984). 98 C. K. Moon, Y. P. Yun, J. H. Lee, H. Wagner, and Y. S. Shin, Planta. Med., 1, 66 (1985). 99 T. Tanimoto, H. Fukuda, J. Kawamura, M. Nakao, U. Shimada, A. Yamada, and C. Tanaka, Chem. Pharm. Bull., 32, 1032 (1984). 100 W. S. Davidson and D. G. Murphy, Enzymology of Carbonyl Metabolism 2: Aldehyde Dehydrogenase, Aldo-Keto Reductase, and Alcohol Dehydrogenase, Alan R. Liss, New York, 1985, p. 251. 101 P. Müller, O. Hockwin, and C. Ohrloff, Ophthalmic Res., 17, 115 (1985). 102 G. Flynn, Biochem. Pharmacol., 31, 2705 (1982). 103 B. Wermuth, Prog. Clin. Biol. Res., 174, 209 (1985). 104 H. B. Markus, M. Raducha, and H. Harris, Biochem. Med., 29, 31 (1983). 105 H.-P. Wirth and B. Wernuth, Prog. Clin. Biol. Res., 174, 231 (1985). 106 H.-P. Wirth and B. Wernuth, FEBS Lett., 187, 280 (1985). 107 B. Wermuth and C. Monder, Eur. J. Biochem., 131, 423 (1983). 108 B. Wermuth, H.-P. Burgisser, K. Bohrn, and J. P. von Wartburg, Eur. J. Biochem., 127, 279 (1982). 109 J. A. Cromlish and T. G. Flynn, Ophthalmic Res., 17, 185 (1985). 110 K. Inagaki, I. Miwa, and J. Okuda, Arch. Biochem. Biophys., 216, 337 (1982). 111 J. A. Cromlish and T. G. Flynn, J. Biol. Chem., 258, 3583 (1983). 112 P. R. Hoffman, B. Wermuth, and J. P. von Wartburg, J. Neurochem., 35, 354 (1980). 113 A. K. Daly and T. J. Mantle, Biochem. J., 205, 373 (1982). 114 J. A. Cromlish and T. G. Flynn, Biochem. J., 209, 597 (1983). 115 B. Wermuth, J. D. B. Munch, and J. P. von Wartburg, J. Biol. Chem., 352, 3821 (1977). 116 C. M. Sheaff and C. C. Doughty, J. Biol. Chem., 251, 2696 (1976). 117 A. B. Halder and M. J. C. Crabbe, Biochem. J., 219, 33 (1984). 118 B. Das and S. K. Srivastava, Diabetes, 34, 1145 (1985). 119 S. K. Srivastava, G. A. Hair, and B. Das, Proc. Natl. Acad. Sci. USA, 82, 7222 (1985). 120 S. K. Srivastava, B. Das, G. A. Hair, R. W. Gracy, S. Awasthi, N. H. Ansarai, and M. J. Petrash, Biochim. Biophys. Acta., 840, 334 (1985). 121 H. B. Feldman, P. A. Szczepanik, P. Havre, R. J. M. Corrall, L. C. Yu, H. M. Rodman, B. A. Rosner, P. D. Klein, and B. R. Landau, Biochem. Biophys. Acta., 480, 14 (1977). 122 D. J. Walton, Biochemistry, 12, 3472 (1973). 123 G. Branlant, Eur. J. Biochem., 121, 407 (1982). 124 A. B. Halder and M. J. C. Crabbe, Ophthalmic Res., 17, 185 (1985). 125 K. H. Gabbay and E. S. Cathcart, Diabetes, 23, 460 (1974). 126 T. G. Flynn, J. Shires, and D. J. Walton, J. Biol. Chem., 250, 2933 (1975). 127 J. A. Cromlish and T. G. Flynn, J. Biol. Chem., 258, 3416 (1983). 128 R. K. Wierenga, M. C. H. DeMaeyer, and W. G. J. Hol, Biochemistry, 24, 1346 (1985). 129 W. R. Kester, and B. W. Matthews, Biochemistry, 16, 2506 (1977). Citing Literature Volume8, Issue2April/June 1988Pages 159-186 ReferencesRelatedInformation
Referência(s)